These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 1833208

  • 41. A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum.
    Andersen PH, Grønvald FC, Jansen JA.
    Life Sci; 1985 Nov 25; 37(21):1971-83. PubMed ID: 2415793
    [Abstract] [Full Text] [Related]

  • 42. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
    McGonigle P, Boyson SJ, Reuter S, Molinoff PB.
    Synapse; 1989 Nov 25; 3(1):74-82. PubMed ID: 2521960
    [Abstract] [Full Text] [Related]

  • 43. Postnatal development of dopamine D1-like and D2-like receptors in the rat kidney: a radioligand binding study.
    Tenore G, Barili P, Sabbatini M, Tayebati SK, Amenta F.
    Mech Ageing Dev; 1997 Apr 25; 95(1-2):1-11. PubMed ID: 9152957
    [Abstract] [Full Text] [Related]

  • 44. Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system.
    Klimek V, Nielsen M.
    Eur J Pharmacol; 1987 Jul 09; 139(2):163-9. PubMed ID: 3308491
    [Abstract] [Full Text] [Related]

  • 45. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy.
    Andersen PH, Jansen JA.
    Eur J Pharmacol; 1990 Jun 12; 188(6):335-47. PubMed ID: 1973652
    [Abstract] [Full Text] [Related]

  • 46. Chemical modification reveals involvement of tyrosine in ligand binding to dopamine D1 and D2 receptors.
    Srivastava LK, Mishra RK.
    Biochem Int; 1990 Jun 12; 21(4):705-14. PubMed ID: 2241996
    [Abstract] [Full Text] [Related]

  • 47. Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine.
    Cass WA, Zahniser NR.
    Synapse; 1990 Jun 12; 5(4):336-7. PubMed ID: 2141733
    [No Abstract] [Full Text] [Related]

  • 48. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K.
    Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7238-41. PubMed ID: 1678519
    [Abstract] [Full Text] [Related]

  • 49. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
    Lau YS, Runice C.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):25-31. PubMed ID: 2865162
    [Abstract] [Full Text] [Related]

  • 50. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M, Schoenleber R, Chung C, McKelvy JF.
    Biochim Biophys Acta; 1989 Nov 27; 986(2):271-80. PubMed ID: 2531613
    [Abstract] [Full Text] [Related]

  • 51. Effect of unilateral perinatal hypoxic-ischemic brain injury on striatal dopamine uptake sites and D1 and D2 receptors in adult rats.
    Kostic VS, Przedborski S, Jackson-Lewis V, Cadet JL, Burke RE.
    Neurosci Lett; 1991 Aug 19; 129(2):197-200. PubMed ID: 1836054
    [Abstract] [Full Text] [Related]

  • 52. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C.
    Proc Natl Acad Sci U S A; 1989 Dec 19; 86(24):10156-60. PubMed ID: 2574862
    [Abstract] [Full Text] [Related]

  • 53. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct 19; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 54. Neurochemical investigation on the effects of a new diphenylpiperazine calcium antagonist, KB-2796, on the central dopaminergic system of rats.
    Ikegami A, Ozaki A, Hara H, Sukamoto T, Yamashita A, Ito K.
    Jpn J Pharmacol; 1992 Apr 19; 58(4):399-405. PubMed ID: 1405037
    [Abstract] [Full Text] [Related]

  • 55. Ascorbic acid inhibits [3H]SCH-23390 binding to striatal dopamine D1 receptors.
    Wiener HL, Lajtha A, Sershen H.
    J Recept Res; 1989 Apr 19; 9(4-5):331-9. PubMed ID: 2531799
    [Abstract] [Full Text] [Related]

  • 56. Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.
    Pugh MT, O'Boyle KM, Molloy AG, Waddington JL.
    Psychopharmacology (Berl); 1985 Apr 19; 87(3):308-12. PubMed ID: 2934758
    [Abstract] [Full Text] [Related]

  • 57. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR.
    Eur J Pharmacol; 1992 Jan 21; 210(3):279-84. PubMed ID: 1351844
    [Abstract] [Full Text] [Related]

  • 58. Effect of prolonged treatment with neuroleptics on dopamine D-1 and D-2 receptor density in corpus striatum of mice.
    Hyttel J.
    Acta Pharmacol Toxicol (Copenh); 1986 Nov 21; 59(5):387-91. PubMed ID: 2880451
    [Abstract] [Full Text] [Related]

  • 59. 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes.
    Coccini T, Manzo L, Costa LG.
    Immunopharmacology; 1991 Nov 21; 22(2):93-105. PubMed ID: 1662188
    [Abstract] [Full Text] [Related]

  • 60. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
    Dong ZJ, Chen LJ, Jin GZ, Creese I.
    Biochem Pharmacol; 1997 Jul 15; 54(2):227-32. PubMed ID: 9271326
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.